Sep.25,2025
FIMECS to Present at the 8th TPD & Induced Proximity Summit
News release
Kanagawa, Japan, 25th September 2025 – FIMECS, Inc. (“FIMECS”), a private biotechnology company pioneering a new class of medicines through targeted protein degradation, today announced that Dr. Kazuteru Aoki, VP Biology will present the company’s latest research at the upcoming 8th TPD & Induced Proximity Summit, taking place in Boston, MA, USA.
Presentation Details:
Title: Unlocking Novel E3 Ligases with an E3-Agnostic Discovery Platform to Expand Degrader Space
Presenter: Dr. Kazuteru Aoki
Time and Date: 2:30 pm – 3:00 pm, Thursday, October 30th, 2025
He will highlight FIMECS’ proprietary RaPPIDS™ platform, a high-throughput synthesis and assay system for targeted protein degradation, and present recent advances in the discovery and application of novel degradable E3 ligase binders that expand the degrader space and broaden drug discovery opportunities.
The TPD & Induced Proximity Summit is the world’s largest international conference dedicated to targeted protein degradation. The summit brings together leading scientists and industry experts to share the latest advances in targeted protein degraders, molecular glues, and induced proximity approaches. The program covers a wide range of topics, from discovery platforms and preclinical/clinical trial results to regulatory and safety considerations.
https://proteindegradation.com/
About FIMECS, Inc.
FIMECS, Inc. is a wholly-owned subsidiary of RaQualia Pharma (TSE:4579). The company is developing a new class of drugs based on targeted protein degradation for the currently ‘undruggable’ targets in immuno-oncology and oncology areas. By integrating proprietary E3 ligase binders and the RaPPIDS™ platform, FIMECS can discover drug candidates that induce the degradation of disease-relevant proteins. This drug discovery platform enable the company to deliver innovative drugs to patients worldwide through both internal and collaboration projects. https://www.fimecs.com/eng/
# # #
FIMECS, Inc. Media and Investor Contact:
FIMECS, Inc.
26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-0012, Japan
Tel: +81-466-96-0261
Email: info@fimecs.com